Compounds for the treatment of inflammatory disorders
This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF—or combinations thereof.
1. A compound selected from the group consisting of
and a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 , selected from the group consisting of:
and a pharmaceutically acceptable salt thereof.
3. The compound of claim 2 , selected from the group consisting of:
and a pharmaceutically acceptable salt thereof.
4. A pharmaceutical composition comprising the compound of claim 1 or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier.